Trials / Completed
CompletedNCT02571257
Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients on Stable Statin Therapy
An 8-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study in Hypercholesterolemic Patients to Determine the Efficacy and Safety of Combination Therapy With CI-1027 and a Statin
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- NeuroBo Pharmaceuticals Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of gemcabene on LDL-C and other lipid parameters in hypercholesterolemic patients on a stable dose of a statin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gemcabene | 1-300 mg tablet, QD, 56 days |
| DRUG | Gemcabene | 3-300 mg tablets, QD, 56 days |
| DRUG | Placebo |
Timeline
- Start date
- 2000-08-01
- Primary completion
- 2002-04-01
- Completion
- 2002-04-01
- First posted
- 2015-10-08
- Last updated
- 2020-04-09
Source: ClinicalTrials.gov record NCT02571257. Inclusion in this directory is not an endorsement.